Why the study?
To determine whether ECG LV strain pattern, its components, and AF predict lower survival at the time of diagnosis of systemic light chain amyloidosis.
Does the presence of ECG LV strain pattern, ST-segment depression, or atrial fibrillation predict overall survival in patients with newly diagnosed systemic AL amyloidosis?
Does the presence of ECG LV strain pattern, ST-segment depression, or atrial fibrillation predict overall survival in patients with newly diagnosed systemic AL amyloidosis?
ECG findings of ST-segment depression and atrial fibrillation do not independently predict reduced survival in systemic AL amyloidosis when adjusted for clinical factors and BNP.
Answers are grounded in this paper and cite their sources.
ST-segment depression and AF should not independently guide prognosis in AL amyloidosis; leaves open ECG strain's value beyond clinical factors and BNP.
BACKGROUND: ST/T abnormalities recognized as electrocardiographic (ECG) left ventricular (LV) strain pattern are known as a marker of myocyte death and reduced survival. The purpose of this study was to determine whether ECG LV strain pattern, its components and atrial fibrillation (AF) predict lower survival at the time of diagnosis of systemic light chain (AL) amyloidosis. METHODS: 12‑lead surface electrocardiogram (ECG), standard two-dimensional echocardiography, laboratory analyses were retrospectively evaluated within 2 months of diagnosis in 87 patients with biopsy-proven systemic AL amyloidosis from 2009 to 2017 in a single center. ECG strain pattern was defined as coexistence of ST-segment horizontal or downward sloping depression ≥0.05 mV at its most horizontal section and negative asymmetrical T-wave deeper than 0.1 mV in at least 1 of leads I,aVL,V1-V6. Patients with QRS >120 ms (BBB or major IVCD) were excluded from the analysis. RESULTS: Kaplan-Meier survival analysis revealed a 1.8-fold shorter overall survival (OS) at 2 years in the ECG strain (21% of participants) group (p = 0.0078), 2.0-fold shorter OS in the ST-segment depression (STd) (isolated and strain related as one group) (34% of participants) group (p < 0.0001), and 3.9-fold shorter OS in AF (23% of participants) group (p < 0.0001) compared with those without. Median survival of patients with STd and AF were and 13.0 (range 1-74) and 9.5 (range 1-74) months respectively. In univariate analysis STd and AF were stronger predictors of inferior OS than relative wall thickness, average E/e' ratio, and LV ejection fraction, but weaker predictors of OS than B-type natriuretic peptide. In multivariate analysis STd and AF lost significance after adjustment for age, gender, number of organs involved and BNP. CONCLUSIONS: ST-segment depression and AF were not significantly associated with reduced survival in AL amyloidosis at diagnosis.
No takes yet. Share an insight, caveat, or question.
Jakaitė et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: